Literature DB >> 6793262

Psychosocial problems in Hunter's syndrome.

I D Young, P S Harper.   

Abstract

During a national study of Hunter's syndrome, visits were made to 33 sets of parents who had had a total of 44 affected sons, 27 with the severe, and 17 with the mild, form of the disease. Information about the behavioural pattern in a further 22 boys was obtained from hospital records. Serious behavioural disturbance was reported in 36 of the 38 severely affected boys, in contrast to those mildly affected, who were generally well behaved but often had serious psychological problems. The effects upon the parents of these boys are discussed. A plea is made that all possible long-term support should be offered both to the families and to the boys themselves.

Entities:  

Mesh:

Year:  1981        PMID: 6793262     DOI: 10.1111/j.1365-2214.1981.tb00838.x

Source DB:  PubMed          Journal:  Child Care Health Dev        ISSN: 0305-1862            Impact factor:   2.508


  11 in total

1.  Health-Related Quality of Life in Patients with MPS II.

Authors:  Mary Needham; Wendy Packman; Natasha Quinn; Maxwell Rappoport; Christa Aoki; Alan Bostrom; Matthew Cordova; Sandra Macias; Cynthia Morgan; Seymour Packman
Journal:  J Genet Couns       Date:  2014-11-14       Impact factor: 2.537

2.  Hearing loss in patients with mucopolysaccharidosis II: data from HOS - the Hunter Outcome Survey.

Authors:  Annerose Keilmann; Todsaporn Nakarat; Iain A Bruce; David Molter; Gunilla Malm
Journal:  J Inherit Metab Dis       Date:  2011-08-25       Impact factor: 4.982

3.  A clinical and genetic study of Hunter's syndrome. 2. Differences between the mild and severe forms.

Authors:  I D Young; P S Harper; R G Newcombe; I M Archer
Journal:  J Med Genet       Date:  1982-12       Impact factor: 6.318

4.  MPS II: adaptive behavior of patients and impact on the family system.

Authors:  Mary Needham; Wendy Packman; Maxwell Rappoport; Natasha Quinn; Matthew Cordova; Sandra Macias; Cynthia Morgan; Seymour Packman
Journal:  J Genet Couns       Date:  2013-11-06       Impact factor: 2.537

5.  Mild form of Hunter's syndrome: clinical delineation based on 31 cases.

Authors:  I D Young; P S Harper
Journal:  Arch Dis Child       Date:  1982-11       Impact factor: 3.791

6.  Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II.

Authors:  G Schulze-Frenking; Simon A Jones; J Roberts; M Beck; J E Wraith
Journal:  J Inherit Metab Dis       Date:  2010-10-27       Impact factor: 4.982

7.  The role of enzyme replacement therapy in severe Hunter syndrome-an expert panel consensus.

Authors:  Joseph Muenzer; Olaf Bodamer; Barbara Burton; Lorne Clarke; Gudrun Schulze Frenking; Roberto Giugliani; Simon Jones; Maria Verónica Muñoz Rojas; Maurizio Scarpa; Michael Beck; Paul Harmatz
Journal:  Eur J Pediatr       Date:  2011-10-29       Impact factor: 3.183

Review 8.  Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy.

Authors:  J Edmond Wraith; Maurizio Scarpa; Michael Beck; Olaf A Bodamer; Linda De Meirleir; Nathalie Guffon; Allan Meldgaard Lund; Gunilla Malm; Ans T Van der Ploeg; Jiri Zeman
Journal:  Eur J Pediatr       Date:  2007-11-23       Impact factor: 3.183

9.  Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type II.

Authors:  Hélène F E Gleitz; Claire O'Leary; Rebecca J Holley; Brian W Bigger
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

10.  Review of the use of idursulfase in the treatment of mucopolysaccharidosis II.

Authors:  T Andrew Burrow; Nancy D Leslie
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.